hydroquinone has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Urra, FA | 1 |
| Muñoz, F | 1 |
| Córdova-Delgado, M | 1 |
| Ramírez, MP | 1 |
| Peña-Ahumada, B | 1 |
| Rios, M | 1 |
| Cruz, P | 1 |
| Ahumada-Castro, U | 1 |
| Bustos, G | 1 |
| Silva-Pavez, E | 1 |
| Pulgar, R | 1 |
| Morales, D | 1 |
| Varela, D | 1 |
| Millas-Vargas, JP | 1 |
| Retamal, E | 1 |
| Ramírez-Rodríguez, O | 1 |
| Pessoa-Mahana, H | 1 |
| Pavani, M | 1 |
| Ferreira, J | 1 |
| Cárdenas, C | 1 |
| Araya-Maturana, R | 1 |
1 other study available for hydroquinone and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
FR58P1a; a new uncoupler of OXPHOS that inhibits migration in triple-negative breast cancer cells via Sirt1/AMPK/β1-integrin pathway.
Topics: AMP-Activated Protein Kinases; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Ener | 2018 |